findmyKOL
Clinical trialNCT01235754CompletedPhase 3Interventional

Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

SponsorBioSante PharmaceuticalsEnrollment626Hypoactive Sexual Desire Disorder
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this study is to evaluate the persistence of benefit of LibiGel (testosterone gel) 300 mcg/day compared to placebo gel in a 12 week post-treatment period of Hypoactive Sexual Desire Disorder (HSDD) in surgically menopausal women.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

102 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Biosante Site# 123

    Ottawa, Ontario, Canada

  • Biosante Site #188

    Sarnia, Ontario, Canada

  • Biosante Site #054

    Windsor, Ontario, Canada

  • Biosante Site #193

    Shawinigan, Quebec, Canada

United States
  • Biosante Site #095

    Hoover, Alabama, United States

  • Biosante Site #014

    Huntsville, Alabama, United States

  • Biosante Site #146

    Mobile, Alabama, United States

  • Biosante Site #171

    Chandler, Arizona, United States

  • Biosante Site #027

    Glendale, Arizona, United States

  • Biosante Site #145

    Glendale, Arizona, United States

  • Biosante Site #121

    Phoenix, Arizona, United States

  • Biosante Site #137

    Tucson, Arizona, United States

  • Biosante Site #052

    Hot Springs, Arkansas, United States

  • Biosante Site #155

    Little Rock, Arkansas, United States

  • Biosante Site #221

    Berkeley, California, United States

  • Biosante Site #182

    Buena Park, California, United States

  • Biosante Site #162

    Sacramento, California, United States

  • Biosante Site #008

    San Diego, California, United States

  • Biosante Site #159

    Walnut Creek, California, United States

  • Biosante Site #007

    Denver, Colorado, United States

  • Biosante Site #026

    Lakewood, Colorado, United States

  • Biosante Site #132

    New Britain, Connecticut, United States

  • Biosante Site #151

    New London, Connecticut, United States

  • Biosante Site #036

    Ridgefield, Connecticut, United States

  • Biosante Site #143

    Jacksonville, Florida, United States

  • Biosante Site #024

    Miami, Florida, United States

  • Biosante Site #111

    Orlando, Florida, United States

  • Biosante Site #219

    Pinellas Park, Florida, United States

  • Biosante Site #041

    St. Petersburg, Florida, United States

  • Biosante Site #009

    West Palm Beach, Florida, United States

  • Biosante Site #115

    Atlanta, Georgia, United States

  • Biosante Site #141

    Roswell, Georgia, United States

  • Biosante Site #202

    Idaho Falls, Idaho, United States

  • Biosante Site #017

    Meridian, Idaho, United States

  • Biosante Site #189

    Addison, Illinois, United States

  • Biosante Site #133

    Chicago, Illinois, United States

  • Biosante Site #167

    Newburgh, Indiana, United States

  • Biosante Site #163

    Overland Park, Kansas, United States

  • Biosante Site #214

    Lexington, Kentucky, United States

  • Biosante Site #110

    Metarie, Louisiana, United States

62 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Placebo gelTransdermal testosterone gel 1%
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2010
Primary completion
31 Dec 2011
Completion
31 Jan 2012
Last update posted
10 Jan 2013
Registered enrollment
626
Registry id
NCT01235754
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.